CYP2C19 Genetic Testing After PCI: A Promising Tool That Still Raises Practical Questions

from TheBrief.Health · host TheBrief.Health

CYP2C19 genotyping may personalize antiplatelet therapy after PCI, identifying patients at risk for reduced clopidogrel response while supporting more targeted treatment decisions.

Episode metadata supplied by the publisher feed · Published Aug 7, 2026

Embed this episode

Attribution link and audio player

NOW PLAYING

CYP2C19 Genetic Testing After PCI: A Promising Tool That Still Raises Practical Questions

0:00 1:57

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of TheBrief.Health?

This episode is 1 minute long.

When was this TheBrief.Health episode published?

This episode was published on August 7, 2026.

Can I download this TheBrief.Health episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!